DLocal (DLO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Hims & Hers Health (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. How do you find the ...

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the ...

Signet (SIG - Free Report) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.01 ...

Detailed price information for Energy Transfer LP (ET-N) from The Globe and Mail including charting and trades.

CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Bank of Montreal, which belongs to the Zacks Banks - Foreign industry, posted revenues of $6.11 billion for the quarter ended ...

The Zacks Rank is a unique, proprietary stock-rating model that utilizes earnings estimate revisions to help investors build a winning portfolio. There are four main factors behind the Zacks Rank ...